|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 167.2 USD | +2.08% |
|
-2.49% | +7.92% |
| 07-05 | Sector Update: Health Care Stocks Steady Premarket Friday | MT |
| 07-05 | AbbVie Flags Hit to Q2 Adjusted Earnings from R&D Expenses, Revises 2024 Outlook | MT |
AbbVie announced that it expects full year 2015 earnings per share of USD 4.25 to USD 4.45 on an adjusted basis. The company anticipates GAAP diluted earnings per share in USD 3.99 to USD 4.19 range for the full-year 2015. According to the company, the midpoint of the 2015 guidance range reflects adjusted earnings-per-share growth of more than 30% from its previous 2014 adjusted EPS guidance.
It intends to further refine its 2015 guidance as the HCV launch progresses.
| 1st Jan change | Capi. | |
|---|---|---|
| +7.92% | 295B | |
| +56.89% | 823B | |
| +40.45% | 627B | |
| -6.55% | 353B | |
| +15.99% | 320B | |
| +14.17% | 239B | |
| +14.55% | 220B | |
| -0.25% | 219B | |
| +7.94% | 167B | |
| -2.57% | 159B |
ABBVIE INC. 
